Related Experiment Videos
Management of the primary cutaneous lymphomas
H Miles Prince1, Christopher McCormack, Gail Ryan
1Department of Haematology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. miles.prince@petermac.org
The Australasian Journal of Dermatology
|November 18, 2003
Summary
Cutaneous lymphomas primarily affect the skin and include T- and B-cell subtypes. Treatment ranges from traditional methods to newer targeted therapies like monoclonal antibodies for these rare skin cancers.
Area of Science:
- Dermatology
- Oncology
- Hematology
Background:
- Cutaneous lymphomas are rare cancers originating in the skin.
- They encompass diverse T- and B-cell subtypes, posing diagnostic challenges.
- Understanding their primary cutaneous origin is key.
Purpose of the Study:
- To provide an overview of primary cutaneous lymphomas.
- To discuss the diagnostic complexities.
- To review current and emerging therapeutic strategies.
Main Methods:
- Literature review of classical and novel treatment modalities.
- Classification of primary cutaneous lymphomas.
- Discussion of therapeutic approaches.
Main Results:
- Primary cutaneous lymphomas present a spectrum of T- and B-cell disorders.
- Diagnosis and classification can be challenging.
- A range of treatments exist, from topical corticosteroids to advanced biologics.
Conclusions:
- Effective management of cutaneous lymphomas requires understanding their diverse nature.
- Therapeutic options are expanding, offering new hope for patients.
- Continued research into targeted therapies is crucial.